CONMED Corp — Director's Dealing 2022

Feb 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-02-25

Reporting Person: Peters Stanley W III (VP GM Advanced Surgery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-25	Common Stock	M	2700	$39.87	Acquired	2763	Direct
2022-02-25	Common Stock	S	2700	$148.00	Disposed	63	Direct
2022-02-25	Common Stock	M	8000	$41.93	Acquired	8063	Direct
2022-02-25	Common Stock	S	6418	$148.357	Disposed	1645	Direct
2022-02-25	Common Stock	S	1582	$149.356	Disposed	63	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-25	Options To Purchase Common Stock	$39.87	M	2700	Disposed	2026-03-01	Common Stock (2700)	Direct
2022-02-25	Options To Purchase Common Stock	$41.93	M	8000	Disposed	2027-03-01	Common Stock (8000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.